Key Details
Price
$1.55Annual ROE
-58.61%Beta
1.60Events Calendar
Next earnings date:
Mar 25, 2025Recent quarterly earnings:
Nov 14, 2024Recent annual earnings:
Mar 25, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Jan 27, 2023Analyst ratings
Recent major analysts updates
Apr 30, 24 Ladenburg Thalmann
BuyFeb 17, 22 Roth Capital
NeutralMar 25, 21 Piper Sandler
OverweightMar 19, 21 Cantor Fitzgerald
OverweightMar 18, 21 Cantor Fitzgerald
OverweightMay 12, 20 Piper Sandler
NeutralNov 13, 19 Piper Jaffray
OverweightNov 13, 19 Janney Capital
BuyJul 3, 19 Oppenheimer
OutperformMay 30, 19 Roth Capital
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Marker Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Marker Therapeutics?
- Does Marker Therapeutics pay dividends?
- What sector is Marker Therapeutics in?
- What industry is Marker Therapeutics in?
- What country is Marker Therapeutics based in?
- When did Marker Therapeutics go public?
- Is Marker Therapeutics in the S&P 500?
- Is Marker Therapeutics in the NASDAQ 100?
- Is Marker Therapeutics in the Dow Jones?
- When was Marker Therapeutics's last earnings report?
- When does Marker Therapeutics report earnings?
- Should I buy Marker Therapeutics stock now?
What is the ticker symbol for Marker Therapeutics?
The ticker symbol for Marker Therapeutics is NASDAQ:MRKR
Does Marker Therapeutics pay dividends?
No, Marker Therapeutics does not pay dividends
What sector is Marker Therapeutics in?
Marker Therapeutics is in the Healthcare sector
What industry is Marker Therapeutics in?
Marker Therapeutics is in the Biotechnology industry
What country is Marker Therapeutics based in?
Marker Therapeutics is headquartered in United States
When did Marker Therapeutics go public?
Marker Therapeutics's initial public offering (IPO) was on July 16, 2002
Is Marker Therapeutics in the S&P 500?
No, Marker Therapeutics is not included in the S&P 500 index
Is Marker Therapeutics in the NASDAQ 100?
No, Marker Therapeutics is not included in the NASDAQ 100 index
Is Marker Therapeutics in the Dow Jones?
No, Marker Therapeutics is not included in the Dow Jones index
When was Marker Therapeutics's last earnings report?
Marker Therapeutics's most recent earnings report was on Nov 14, 2024
When does Marker Therapeutics report earnings?
The next expected earnings date for Marker Therapeutics is Mar 25, 2025
Should I buy Marker Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions